➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
Colorcon
Johnson and Johnson
McKinsey

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

DESIPRAMINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Desipramine Hydrochloride patents expire, and when can generic versions of Desipramine Hydrochloride launch?

Desipramine Hydrochloride is a drug marketed by Actavis Totowa, Amneal Pharms Co, Ani Pharms Inc, Heritage Pharms Inc, Novast Labs, Sandoz, and Usl Pharma. and is included in twenty NDAs.

The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Desipramine Hydrochloride

A generic version of DESIPRAMINE HYDROCHLORIDE was approved as desipramine hydrochloride by ACTAVIS TOTOWA on June 5th, 1987.

  Start Trial

Drug patent expirations by year for DESIPRAMINE HYDROCHLORIDE
Recent Clinical Trials for DESIPRAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 4
Stanford UniversityPhase 4
Astellas Pharma IncPhase 4

See all DESIPRAMINE HYDROCHLORIDE clinical trials

Pharmacology for DESIPRAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DESIPRAMINE HYDROCHLORIDE

US Patents and Regulatory Information for DESIPRAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 072104-001 Jun 20, 1988 AB RX No No   Start Trial   Start Trial   Start Trial
Novast Labs DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-003 Dec 26, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Usl Pharma DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071867-001 Sep 9, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 207433-005 May 5, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Novast Labs DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-004 Dec 26, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 207433-006 May 5, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 074430-001 Feb 9, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Dow
Express Scripts
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.